These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6240395)

  • 1. Experimental maternal phenylketonuria: an examination of two animal models.
    Loo YH; Rabe A; Potempska A; Wang P; Fersko R; Wisniewski HM
    Dev Neurosci; 1983-1984; 6(4-5):227-34. PubMed ID: 6240395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary mixtures of amino acids on fetal growth and maternal and fetal amino acid pools in experimental maternal phenylketonuria.
    Austic RE; Su CL; Strupp BJ; Levitsky DA
    Am J Clin Nutr; 1999 Apr; 69(4):687-96. PubMed ID: 10197570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical effects of induced phenylketonuria in rats.
    Poncet IB; Berry HK; Butcher RE; Kazmaier KJ
    Biol Neonate; 1975; 26(1-2):88-101. PubMed ID: 125115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal phenylketonuria. Review with emphasis on pathogenesis.
    Levy HL
    Enzyme; 1987; 38(1-4):312-20. PubMed ID: 3326736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine.
    Loo YH; Scotto J; Wisniewski HM
    Adv Exp Med Biol; 1978; 100():453-69. PubMed ID: 151497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal phenylketonuria: a metabolic teratogen.
    Levy HL; Ghavami M
    Teratology; 1996 Mar; 53(3):176-84. PubMed ID: 8761885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal hyperphenylalaninemia: an experimental model in rats.
    Andersen A
    Dev Psychobiol; 1976 Mar; 9(2):157-66. PubMed ID: 986972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenylalanine loading on protein synthesis in the fetal heart and brain of rat: an experimental approach to maternal phenylketonuria.
    Okano Y; Chow IZ; Isshiki G; Inoue A; Oura T
    J Inherit Metab Dis; 1986; 9(1):15-24. PubMed ID: 2941618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental hyperphenylalaninemia in the pregnant guinea pig: possible phenylalanine teratogenesis and p-chlorophenylalanine embryotoxicity.
    Kronick JB; Whelan DT; McCallion DJ
    Teratology; 1987 Oct; 36(2):245-58. PubMed ID: 2962329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral biochemical abnormalities in experimental maternal phenylketonuria: gangliosides and sialoglycoproteins.
    Loo YH; Hyde KR; Lin FH; Wisniewski HM
    Life Sci; 1985 Dec; 37(22):2099-109. PubMed ID: 4068896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of hyperphenylalaninemia on fetal development: a new animal model of maternal phenylketonuria.
    Brass CA; Isaacs CE; McChesney R; Greengard O
    Pediatr Res; 1982 May; 16(5):388-94. PubMed ID: 7201630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of experimental phenylketonuria. Augmentation of hyperphenylalaninemia with alpha-methylphenylalanine and p-chlorophenylalanine.
    Lane JD; Schöne B; Langenbeck U; Neuhoff V
    Biochim Biophys Acta; 1980 Jan; 627(2):144-56. PubMed ID: 6444271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The maternal phenylketonuria syndrom--still current problem].
    Didycz B; Domagała L; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in experimental phenylketonuria: a critical review.
    Vorhees CV; Butcher RE; Berry HK
    Neurosci Biobehav Rev; 1981; 5(1):177-90. PubMed ID: 6453302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
    Bouchlariotou S; Tsikouras P; Maroulis G
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal phenylketonuria: comparison of two treated full term pregnancies.
    Soeters RP; Sengers RC; van Dongen PW; Trijbels JM; Eskes TK
    Eur J Pediatr; 1986 Aug; 145(3):221-3. PubMed ID: 3769979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry.
    Grange DK; Hillman RE; Burton BK; Yano S; Vockley J; Fong CT; Hunt J; Mahoney JJ; Cohen-Pfeffer JL; ;
    Mol Genet Metab; 2014 May; 112(1):9-16. PubMed ID: 24667082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral deficit in phenylketonuric rats: role of aromatic acid metabolites of phenylalanine.
    Kaplan H; Triano T; Donadio M
    Dev Psychobiol; 1981 May; 14(3):201-7. PubMed ID: 7196355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuria.
    Grohmann-Held K; Burgard P; Baerwald CGO; Beblo S; Vom Dahl S; Das A; Dokoupil K; Fleissner S; Freisinger P; Heddrich-Ellerbrok M; Jung A; Korpel V; Krämer J; Lier D; Maier EM; Meyer U; Mühlhausen C; Newger M; Och U; Plöckinger U; Rosenbaum-Fabian S; Rutsch F; Santer R; Schick P; Schwarz M; Spiekerkötter U; Strittmatter U; Thiele AG; Ziagaki A; Mütze U; Gleich F; Garbade SF; Kölker S
    J Inherit Metab Dis; 2022 Nov; 45(6):1070-1081. PubMed ID: 36054426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.